Our CEO Ryu Ogawa will speak at the “SmartPitch” Vol.11 on April 7th. 4月7日開催の「SmartPitch」 オンラインピッチイベントVol.11にて […]
株式会社MOLCURE（本社：神奈川県川崎市、代表取締役：小川隆、以下MOLCURE）と株式会社FRONTEO（本社：東京都港区、代表取締役社長：守本 正宏、以下FRONTEO）とは、AIを活用した創薬DX（デジタル・ト […]
An interview with our CEO Ryu Ogawa was published in AnswersNews. AnswersNewsに、CEO小川のインタビューが掲載されました。 Link to a […]
Our CSO Satoshi Tamaki will speak at the ”Startup Creative Lab seminar” on Feb 26th. 2月26日開催の「Startup Creative […]
An academic paper on “High-throughput screening of peptides using mRNA/cDNA display,” conducted jointly by res […]
Our article about laboratory automation was published in Experimental Medicine Vol.39 No.1 2021 実験医学「新型コロナで変わる […]
MOLCURE’s work on drug discovery using AI and robotics was featured in the Nikkei Business Daily. MOLCUREのAIとロ […]
Our CEO Ryu Ogawa will speak at the “KBIC Pitch Vol. 1” on Feb 3, 15:29 JST. 2月3日開催の「KBIC Pitch vol,１（ 資金調達/協業 […]
MOLCURE has been selected for Microsoft for Startups, a start-up program supported by Microsoft. Microsoft for […]
An interview with our CEO Ryu Ogawa was published in the web magazine EL BORDE. ウェブマガジン EL BORDEに、CEO 小川のインタビュ […]